Japan stocks higher at close of trade Nikkei 225 up 0.95%


(MENAFN- FxPro) Japan stocks were higher after the close on Thursday, as gains in the Transportation Equipment, Financial Services and Pharmaceutical Industry sectors led shares higher.

At the close in Tokyo, the Nikkei 225 rose 0.95%.

The best performers of the session on the Nikkei 225 were Sharp Corp. (TOKYO:6753), which rose 8.61% or 13.0 points to trade at 164.0 at the close. Meanwhile, Tokyu Fudosan (TOKYO:3289) added 4.38% or 42.0 points to end at 1001.0 and Sony Financial Holdings Inc. (TOKYO:8729) was up 3.87% or 86.0 points to 2307.0 in late trade.

The worst performers of the session were SUMCO Corp. (TOKYO:3436), which fell 2.71% or 42.0 points to trade at 1507.0 at the close. Kawasaki Heavy Industries, Ltd. (TOKYO:7012) declined 2.43% or 14.0 points to end at 563.0 and Mitsubishi Heavy Industries, Ltd. (TOKYO:7011) was down 2.29% or 17.2 points to 734.1.

Rising stocks outnumbered declining ones on the Tokyo Stock Exchange
by 1320 to 562.

Shares in Tokyu Fudosan (TOKYO:3289) rose to 52-week highs; rising 4.38% or 42.0 to 1001.0. Shares in Sony Financial Holdings Inc. (TOKYO:8729) rose to all time highs; rising 3.87% or 86.0 to 2307.0.

The Nikkei Volatility, which measures the implied volatility of Nikkei 225 options, was down 4.95% to 19.40.

Crude oil for August delivery was up 0.38% or 0.21 to $57.17 a barrel. Elsewhere in commodities trading, Brent oil for delivery in August rose 0.58% or 0.36 to hit $62.37 a barrel, while the August Gold contract fell 0.38% or 4.40 to trade at $1164.90 a troy ounce.

USD/JPY was up 0.20% to 123.42, while EUR/JPY rose 0.44% to 136.74.

The US Dollar Index was down 0.13% at 96.35.


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.